ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $90,964,000 | +419.9% | 528,554 | +279.1% | 0.03% | +433.3% |
| Q2 2021 | $17,497,000 | +11.8% | 139,425 | +20.9% | 0.01% | -14.3% |
| Q1 2021 | $15,645,000 | +348.7% | 115,366 | +323.3% | 0.01% | +600.0% |
| Q4 2020 | $3,487,000 | -52.1% | 27,256 | -57.9% | 0.00% | -80.0% |
| Q3 2020 | $7,277,000 | -75.5% | 64,673 | -79.3% | 0.01% | -78.3% |
| Q2 2020 | $29,738,000 | +302.1% | 312,143 | +279.4% | 0.02% | +228.6% |
| Q1 2020 | $7,395,000 | +1558.1% | 82,280 | +629.0% | 0.01% | +600.0% |
| Q3 2019 | $446,000 | +34.7% | 11,286 | +40.2% | 0.00% | 0.0% |
| Q2 2019 | $331,000 | +32.4% | 8,048 | +25.7% | 0.00% | 0.0% |
| Q1 2018 | $250,000 | -43.9% | 6,404 | -39.1% | 0.00% | 0.0% |
| Q4 2017 | $446,000 | -69.5% | 10,519 | -73.1% | 0.00% | -80.0% |
| Q3 2017 | $1,461,000 | +558.1% | 39,137 | +758.8% | 0.01% | +400.0% |
| Q4 2015 | $222,000 | -55.3% | 4,557 | -68.8% | 0.00% | -83.3% |
| Q2 2014 | $497,000 | – | 14,621 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |